Will Merck be next to join Big Pharma's asset-sale parade? November 6, 2013 | By Tracy Staton Read more: Will Merck be next to join Big Pharma's asset-sale parade? - Is it going to spin off its animal drug section?

Novartis ($NVS) is on its way to selling a business--or three. Pfizer ($PFE) is laying the operational groundwork for potential follow-ups to its nutrition unit sale and animal health spinoff. Abbott Laboratories ($ABT) set its pharma business free at the beginning of this year. Why wouldn't Merck ($MRK) decide to join the slim-down club?

Read more: Will Merck be next to join Big Pharma's asset-sale parade? - FiercePharma http://www.fiercepharma.com/story/will-merck-be-next-join-big-pharmas-asset-sale-parade/2013-11-06#ixzz2jwGEsWqo
Subscribe at FiercePharma